Drug intelligence / Profile preview

Ring Guard

Development stage
Unknown
Lead developer
Reckitt
Modality
Small Molecules, Drug Delivery Systems
Administration
Topical
01

Overview

Ring Guard is an over-the-counter topical combination antifungal and antibacterial cream, marketed primarily for the treatment of superficial dermatologic infections such as ringworm (tinea corporis), jock itch (tinea cruris), athlete’s foot (tinea pedis), and other mixed fungal and bacterial skin infections. It is formulated with the imidazole antifungal miconazole nitrate, which inhibits ergosterol synthesis in fungal cell membranes, and the aminoglycoside antibiotic neomycin sulfate, which binds bacterial 30S ribosomal subunits to block protein synthesis, together providing broad coverage against susceptible dermatophytes, yeasts, and bacteria. The product is used topically on affected skin to relieve symptoms such as itching, burning, redness, and irritation and is available in several branded variants (e.g., Plus, Advance) with the same core mechanism focused on local eradication of cutaneous fungal and bacterial pathogens.[1][3][4][7][8][9][11]

Brand names
Ring GuardRing Guard CreamRing Guard PlusRing Guard Advance
02

Targets

Bacterial RibosomeCYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Ring Guard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ring Guard.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call